Koss-Olinger Consulting’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Koss-Olinger Consulting's LLY Position: Q1 2026 in Review
Koss-Olinger Consulting sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 487 shares — an estimated $524K sold.
Koss-Olinger Consulting first reported a position in LLY in Q1 2021 and held it in 14 quarters. The position peaked at $5.15M in Q1 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Koss-Olinger Consulting reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
- Koss-Olinger Consulting sold 487 Eli Lilly shares in Q1 2026, an estimated $524K.
- Koss-Olinger Consulting first reported a position in Eli Lilly in Q1 2021 and held it in 14 quarters.
- Koss-Olinger Consulting's Eli Lilly position peaked at $5.15M in Q1 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Koss-Olinger Consulting's 13F filing for Q1 2026, filed 7 May 2026.